Researchers from the Queen Mary University of London have found that age-related macular degeneration is potentially caused by the failure of at least one of five proteins to regulate the immune system.
Previous research has shown that inflammation at the back of the eye plays a factor in the development of macular degeneration. In addition, genes that regulate our immune defense against pathogens were identified as factors that increase the risk of developing macular degeneration.
The most recent research found that all five FHR proteins are at higher levels in people with macular degeneration than in people without the condition. Researchers were able to identify genetic variants that determine both higher FHR protein levels and increased risk of macular degeneration.
Results of this study have the potential of helping with the development of treatments for macular degeneration as well as a test to determine which people are at risk of developing macular degeneration.
While there currently is no treatment for the dry form of macular degeneration. VisiVite offers a selection of AREDS 2 supplements to support retinal health in those who have been diagnosed with macular degeneration.